Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach-Reference-Cited by-同舟云学术

Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach

Published:2022-03-08 Issue:2 Volume:8 Page:149-170
ISSN:2198-641X
Container-title:Current Pharmacology Reports
language:en
Short-container-title:Curr Pharmacol Rep

Author:

Rolta Rajan,Salaria Deeksha,Sharma Bhanu,Awofisayo Oladoja,Fadare Olatomide A.,Sharma Sonum,Patel Chirag N.,Kumar Vikas,Sourirajan Anuradha,Baumler David J.,Dev Kamal

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,Genetics,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s40495-021-00276-3.pdf

Reference55 articles.

1. Pal M, Berhanu G, Desalegn C, Kandi V. Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2): An update. Cureus. 2020;e7423. https://doi.org/10.7759/cureus.7423

2. Abdul-Rasool S, Fielding BC. Understanding human coronavirus HCoV-NL63. Open Virol J. 2010;4:76. https://doi.org/10.2174/1874357901004010076

3. ••Muralidharan N, Sakthivel R, Velmurugan D, Gromiha MM. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. J Biomol Struct Dynam. 2020;1–6. https://doi.org/10.1080/07391102.2020.1752802. This in silico study explored the effect of synergism of the drugs, lopinavir, oseltamivir and ritonavir against the SARS-CoV-2 protease.

4. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382:970–1. https://doi.org/10.1056/NEJMc2001468.

5. Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan S, Yuen KY. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infec. 2020;9:221–36. https://doi.org/10.1080/22221751.2020.1719902.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytoconstituents as modulator of inflammatory pathways for COVID‐19: A comprehensive review and recommendations;Phytotherapy Research;2024-09-09

2. In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19;Phytomedicine;2024-07

3. Association of dietary intake of theobromine with periodontitis: NHANES 2009-2014;2024-06-28

4. Biological properties of caffeine, (+)-catechin, and theobromine: an in silico study;3 Biotech;2024-03-03

5. Recent advances on the therapeutic potential with Ocimum species against COVID-19: A review;South African Journal of Botany;2024-01